Posts Tagged ‘CDMO’

HomeCDMO

In addition to strengthening environmental protection spending by adopting solar green electricity and successfully passing ISO 14064-1 and ISO 14067 certifications in recent years, Taiyao has also made significant progress in ESG initiatives, including a three-year consecutive decline in process water consumption and a continued increase in recycled water volume. Furthermore, it has established a caring and supportive work environment, and its R&D investment has increased for three consecutive years, with its proportion of revenue also expanding. Besides its CDMO business contributing revenue to multiple countries, Taiyao continues to contribute to the healthcare sector, demonstrating its commitment to corporate sustainability.

Polaris Pharmaceuticals focuses on developing metabolic therapy drugs for cancer to alleviate patient discomfort and reduce side effects. In 2022, the company achieved a milestone by completing its clinical trial for lung mesothelioma, and several of its cancer drugs have entered Phase III clinical trials, moving towards obtaining drug approvals in various countries. In addition, the company undertakes contract development and manufacturing organization (CDMO) services for biopharmaceuticals, and its R&D investment has been increasing year by year. In the future, it will implement an automated management system to monitor energy consumption.